Panacor Bioscience Limited concentrates on new drug development and has several drug candidates in the pipeline targeting poorly met medical needs. The company has the necessary expertise to bring technologies through the development stage and regulatory process to move them to commercialization with success. Panacor is strategically located in Asia and has access to early or mid-phase products from research institution to build a broad portfolio of products.